DISCOVERX CORP

FREMONT, CA · Biotech · Acquired

Cell-based assay platforms and services for drug discovery

Claim this profile

Follows are private to you and power your alerts

Updated · discoverx.com

Sector
Biotech
Headquarters
FREMONT, CA
Latest Form D
$8M, Nov 2010
Total capital
$15.6M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$8M
2 Form D · last Nov 2010
192 months since last filing
Federal contracts
$7.6M
7 awards · Environmental Prot
Rank in Biotech#66 of 4373
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

200920102011201220132014FEDERAL ↑EQUITY ↓Cumulative $15.7M$1.7M$1M$473K$696K$278K$3.1M1st Form D$168K2nd Form D$8M
200920102011201220132014FEDERAL ↑EQUITY ↓Cumulative $15.7M$1.7M$1M$696K$3.1M1st Form D$168K2nd Form D$8M

Latest events

  • Federal contractEnvironmental Prot · Igf::ot::igf Complex Cell System Bioanalysis Of The Toxcast Compound Library$3.1M
  • Federal contractEnvironmental Prot · Igf::ot::igf Other Functions Bioseek EP-W-07-039 New "nano" Task Order$278K
  • Federal contractEnvironmental Prot · Bioseek PHASE2C Order$696K
  • Federal contractEnvironmental Prot · Bioseek - TO5 - Nano Funding - $269,700.00$270K
  • Private capital raisedForm D · SEC · 2nd filing$8M
  • Offering registeredForm D · SEC · 1st filing$168K
  • Federal contractEnvironmental Prot · Toxcast Support$473K
Show 2 earlier federal awards
  • Federal contractEnvironmental Prot · Toxcast Support$1M
  • Federal contractEnvironmental Prot · Toxcast Phase II$1.7M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

15months

from DISCOVERX CORP’s first federal award to its first private round.

First federal award · Jun 2009
Environmental Prot · $1.7M
First Form D · Sep 2010
$168K · 1st Form D
Awards before first raise
3 awards

An association in public records, not a cause or a prediction.

Founders and team

From SEC Form D filings
  • Daniel JanneyDirectorNamed in SEC Form D filings
  • Esfandiar LohrasbpourDirectorNamed in SEC Form D filings
  • John FreundDirectorNamed in SEC Form D filings
  • Melissa DanielsDirectorNamed in SEC Form D filings
  • Pyare KhannaExecutive Officer, DirectorNamed in SEC Form D filings
  • Richard BastianiDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .